12:00 AM
 | 
Feb 16, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Trabectedin regulatory update

Swissmedic approved Yondelis trabectedin from PharmaMar to treat soft tissue sarcoma (STS). PharmaMar already markets the cytotoxic alkaloid that binds the minor groove of DNA in the...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >